These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 6103859

  • 1. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T, Taminato T, Kadowaki S, Abe H, Chihara K, Seino Y, Matsukura S, Fujita T.
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [Abstract] [Full Text] [Related]

  • 2. Effects of vasoactive intestinal peptide and secretin on gastrin and somatostatin secretion in the perfused rat stomach.
    Saffouri B, DuVal JW, Arimura A, Makhlouf GM.
    Gastroenterology; 1984 May; 86(5 Pt 1):839-42. PubMed ID: 6142844
    [Abstract] [Full Text] [Related]

  • 3. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.
    Ipp E, Dobbs RE, Harris V, Arimura A, Vale W, Unger RH.
    J Clin Invest; 1977 Nov; 60(5):1216-9. PubMed ID: 908761
    [Abstract] [Full Text] [Related]

  • 4. Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.
    Simon B, Kather H.
    Gastroenterology; 1978 Apr; 74(4):722-5. PubMed ID: 204535
    [Abstract] [Full Text] [Related]

  • 5. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
    Domschke S, Bloom SR, Adrian TE, Lux G, Domschke W.
    Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
    [Abstract] [Full Text] [Related]

  • 6. Effects of various gastrointestinal peptides on gastric somatostatin release.
    Chiba T, Taminato T, Kadowaki S, Inoue Y, Mori K, Seino Y, Abe H, Chihara K, Matsukura S, Fujita T, Goto Y.
    Endocrinology; 1980 Jan; 106(1):145-9. PubMed ID: 7349951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
    Eissele R, Koop H, Arnold R.
    Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
    [Abstract] [Full Text] [Related]

  • 11. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M, Akiyoshi H, Fujii S.
    J Biochem; 1977 Oct; 82(4):1073-6. PubMed ID: 924981
    [Abstract] [Full Text] [Related]

  • 12. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study.
    de la Cour CD, Norlén P, Håkanson R.
    Regul Pept; 2007 Oct 04; 143(1-3):118-26. PubMed ID: 17573135
    [Abstract] [Full Text] [Related]

  • 13. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
    Gespach C, Hui Bon Hoa D, Rosselin G.
    Endocrinology; 1983 May 04; 112(5):1597-606. PubMed ID: 6131813
    [Abstract] [Full Text] [Related]

  • 14. Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin gastric inhibitory polypeptide, and gastrin-17 in dogs.
    Rouiller D, Schusdziarra V, Harris V, Unger RH.
    Endocrinology; 1980 Aug 04; 107(2):524-9. PubMed ID: 6104593
    [No Abstract] [Full Text] [Related]

  • 15. [Somatostatin and opioids, secretin and VIP--protectors of the mucosa?].
    Schusdziarra V, Weigert N.
    Z Gastroenterol; 1987 Aug 04; 25 Suppl 3():56-63. PubMed ID: 2889300
    [Abstract] [Full Text] [Related]

  • 16. Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones.
    Gardner JD, Conlon TP, Adams TD.
    Gastroenterology; 1976 Jan 04; 70(1):29-35. PubMed ID: 173615
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man.
    Domschke S, Domschke W, Rösch W, Konturek SJ, Sprügel W, Mitznegg P, Wünsch E, Demling L.
    Gastroenterology; 1977 Sep 04; 73(3):478-80. PubMed ID: 892345
    [Abstract] [Full Text] [Related]

  • 18. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J, Sandberg E, Efendić S.
    Diabetologia; 1980 Aug 04; 19(2):137-42. PubMed ID: 6106616
    [Abstract] [Full Text] [Related]

  • 19. Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
    Waldman DB, Gardner JD, Zfass AM, Makhlouf GM.
    Gastroenterology; 1977 Sep 04; 73(3):518-23. PubMed ID: 892349
    [No Abstract] [Full Text] [Related]

  • 20. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach.
    Lippl F, Kircher F, Erdmann J, Allescher HD, Schusdziarra V.
    Regul Pept; 2004 Jun 15; 119(1-2):93-8. PubMed ID: 15093702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.